Callan Capital LLC Acquires 996 Shares of Unum Group (NYSE:UNM)

Callan Capital LLC boosted its holdings in Unum Group (NYSE:UNM) by 12.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 9,061 shares of the financial services provider’s stock after buying an additional 996 shares during the period. Callan Capital LLC’s holdings in Unum Group were worth $662,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. International Assets Investment Management LLC grew its holdings in shares of Unum Group by 5,844.0% during the 3rd quarter. International Assets Investment Management LLC now owns 101,048 shares of the financial services provider’s stock worth $6,006,000 after purchasing an additional 99,348 shares in the last quarter. Assenagon Asset Management S.A. grew its holdings in shares of Unum Group by 24.5% during the 3rd quarter. Assenagon Asset Management S.A. now owns 325,796 shares of the financial services provider’s stock worth $19,365,000 after purchasing an additional 64,062 shares in the last quarter. Ballentine Partners LLC grew its holdings in shares of Unum Group by 7.1% during the 3rd quarter. Ballentine Partners LLC now owns 6,806 shares of the financial services provider’s stock worth $405,000 after purchasing an additional 452 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. grew its holdings in shares of Unum Group by 8.1% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 112,273 shares of the financial services provider’s stock worth $6,585,000 after purchasing an additional 8,439 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC grew its holdings in shares of Unum Group by 21.6% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 34,967 shares of the financial services provider’s stock worth $2,078,000 after purchasing an additional 6,202 shares in the last quarter. 86.57% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several analysts recently commented on UNM shares. BMO Capital Markets started coverage on Unum Group in a research note on Thursday, January 23rd. They issued an “outperform” rating and a $91.00 price target on the stock. StockNews.com raised Unum Group from a “hold” rating to a “buy” rating in a research note on Friday, February 14th. Barclays boosted their price target on Unum Group from $76.00 to $85.00 and gave the company an “overweight” rating in a research note on Monday, January 6th. Jefferies Financial Group boosted their price objective on Unum Group from $91.00 to $96.00 and gave the stock a “buy” rating in a research note on Tuesday, December 10th. Finally, Wells Fargo & Company boosted their price objective on Unum Group from $81.00 to $91.00 and gave the stock an “overweight” rating in a research note on Wednesday. Four equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $81.17.

Unum Group Trading Down 1.0 %

UNM stock opened at $74.07 on Friday. The company has a market cap of $13.53 billion, a P/E ratio of 7.82, a PEG ratio of 1.14 and a beta of 0.80. Unum Group has a twelve month low of $48.38 and a twelve month high of $79.43. The company has a quick ratio of 0.28, a current ratio of 0.29 and a debt-to-equity ratio of 0.32. The business has a fifty day moving average of $74.28 and a 200-day moving average of $66.85.

Unum Group (NYSE:UNM) last released its earnings results on Tuesday, February 4th. The financial services provider reported $2.03 earnings per share for the quarter, missing analysts’ consensus estimates of $2.14 by ($0.11). Unum Group had a return on equity of 14.91% and a net margin of 13.81%. As a group, equities research analysts expect that Unum Group will post 9.14 EPS for the current year.

Unum Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Friday, January 24th were issued a $0.42 dividend. The ex-dividend date of this dividend was Friday, January 24th. This represents a $1.68 dividend on an annualized basis and a yield of 2.27%. Unum Group’s dividend payout ratio is presently 17.74%.

Unum Group announced that its board has approved a share repurchase plan on Tuesday, February 18th that authorizes the company to repurchase $1.00 billion in shares. This repurchase authorization authorizes the financial services provider to buy up to 7.4% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s management believes its stock is undervalued.

Insider Activity at Unum Group

In related news, EVP Timothy Gerald Arnold sold 10,000 shares of the company’s stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $76.92, for a total value of $769,200.00. Following the completion of the sale, the executive vice president now owns 54,827 shares in the company, valued at approximately $4,217,292.84. This represents a 15.43 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 0.93% of the stock is currently owned by corporate insiders.

Unum Group Profile

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.